Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins: A study in centenarians

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 4, 1997, Pages 755-759

  Mannucci, P M ^a,e   Mari, D ^a   Merati, G ^a   Peyvandi, F ^a   Tagliabue, L ^a   Sacchi, E ^a   Taioli, E ^a   Sansoni, P ^b   Bertolini, S ^c   Franceschi, C ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e NONE   (Italy)

Author keywords

centenarians; factor VII; fibrinogen; gene polymorphisms; plasminogen activator inhibitor 1

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; FIBRINOLYTIC FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1;

AGED; AGING; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEMOSTASIS; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; HYPERCOAGULABILITY; ITALY; LONGEVITY; MALE; MULTICENTER STUDY; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOSIS;

EID: 16944362695     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.4.755     Document Type: Article

References (22)

1. Meade TW. Hemostatic function, arterial disease and the prevention of arterial thrombosis. In: Thrombophilia. Balliere's Clin Hematol. 1994;7:733-756.
2. Green F, Humphries S. Genetic determinants of arterial thrombosis. In: Thrombophilia. Balliere's Clin Hematol. 1994;7:675-692.
3. Green F, Kelleher C, Wilkes H, Temple A, Meade TW, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb. 1991;11:540-546.
4. Dawson S, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activation inhibitor locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb. 1991;11:183-190.
5. Fowkes FGR, Connor JM, Smith FB, Wood J, Donnan PT, Lowe GDO. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet. 1992;339:693-696.
6. Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP, Arveiler D, Henney AM, Cambien F. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor 1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost. 1995;74:837-841.
7. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today. 1995;16:12-16.
8. Mari D, Mannucci PM, Coppola R, Bottasse B, Bauer KA, Rosenberg RD. Hypercoagulability in centenarians: the paradox of successful ageing. Blood. 1995;85:3144-3149.
9. Mari D, Mannucci PM, Duca F, Bertolini S, Franceschi C. Mutant factor V (Arg506Gln) in healthy centenarians. Lancet. 1995;347:1044.
10. Lighart GJ, Corberand JX, Fournier C, Galanand P, Higmans W, Kennes B, Muller O, Hermelik HK, Stinmann GC. Admission criteria for immunogerontological studies in man: the Senieur Protocol. Mech Ageing Dev. 1984;28:47-55.
11. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human mutated cells. Nucleic Acid Res. 1988;16:1215-1218.
12. Thomas A, Green F, Kelleher C, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the β fib-rinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost. 1991;65:487-490.
13. Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb. 1994,14:193-198.
14. Dawson S, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene responds differently to IL-1 in Hep G2 cells. J Biol Chem. 1993;268:10739-10745.
15. Roff DA, Bentzen P. The statistical analysis of mitochondrial DNA polymorphisms: chi square and the problem of small samples. Mol Biol Evol. 1989;6:539-545.
16. Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2:3-9.
17. Mansfield MW, Stickland MH, Grant PJ. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin dependent diabetes mellitus. Thromb Haemost. 1995;74:842-847.
18. Schächter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Laseur-Ginot L, Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29-32.
19. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard SM, Bara L, Ricard S, Tiret L, Amougel P, Alhenc-Gelas F, Soubrier E. Deletion polymorphism in the gene coding for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
20. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Amougel P, Cambien F. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 1993;341:991-992.
21. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-21.
22. Van Boekmeer FM, Mamotte CDS. Apolipoprotein ε4 homozygosity in young men with coronary heart disease. Lancet. 1992;340: 879-880.